C07F 9/572
Five-membered rings
C07F9/572 (Five-membered rings) appears on 940 US grants and 863 published applications in this corpus.
Search patents in C07F- Granted patents
- 940
- Published applications
- 863
- Assignees
- 511
- Inventors
- 2,503
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 5 | 0 |
| 1978 | 6 | 0 |
| 1979 | 3 | 0 |
| 1980 | 7 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 16 | 0 |
| 1984 | 14 | 0 |
| 1985 | 11 | 0 |
| 1986 | 11 | 0 |
| 1987 | 11 | 0 |
| 1988 | 5 | 0 |
| 1989 | 16 | 0 |
| 1990 | 10 | 0 |
| 1991 | 11 | 0 |
| 1992 | 9 | 0 |
| 1993 | 11 | 0 |
| 1994 | 20 | 0 |
| 1995 | 24 | 0 |
| 1996 | 23 | 0 |
| 1997 | 21 | 0 |
| 1998 | 23 | 0 |
| 1999 | 17 | 0 |
| 2000 | 15 | 0 |
| 2001 | 18 | 1 |
| 2002 | 21 | 26 |
| 2003 | 22 | 29 |
| 2004 | 24 | 45 |
| 2005 | 17 | 35 |
| 2006 | 29 | 37 |
| 2007 | 19 | 27 |
| 2008 | 22 | 36 |
| 2009 | 20 | 35 |
| 2010 | 32 | 29 |
| 2011 | 16 | 26 |
| 2012 | 27 | 27 |
| 2013 | 26 | 34 |
| 2014 | 27 | 22 |
| 2015 | 29 | 38 |
| 2016 | 19 | 34 |
| 2017 | 32 | 41 |
| 2018 | 28 | 37 |
| 2019 | 39 | 35 |
| 2020 | 25 | 25 |
| 2021 | 23 | 25 |
| 2022 | 20 | 36 |
| 2023 | 28 | 53 |
| 2024 | 24 | 52 |
| 2025 | 25 | 49 |
| 2026 | 18 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids4 Aug 2026US 12,697,564 B2
- Oxopyrrolidine FPR2 agonists14 Jul 2026US 12,679,823 B2Bristol-Myers Squibb Company
- Conjugates including a detectable moiety7 Jul 2026US 12,673,938 B2Ventana Medical Systems, Inc.
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use30 Jun 2026US 12,668,605 B2Compass Pathfinder Limited
- Non-Peptide Small Molecule FGF14:Nav1.6 Channel Complex Protein-Protein Interaction Modulators1 Oct 2026US 2026/0297027 A1Board of Regents, The University of Texas System
- Conjugates including a detectable moiety1 Oct 2026US 2026/0297063 A1Ventana Medical Systems, Inc.
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use10 Sep 2026US 2026/0265276 A1Compass Pathfinder Limited
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use10 Sep 2026US 2026/0265277 A1Compass Pathfinder Limited
- Processes of preparing psilocin and psilocybin10 Sep 2026US 2026/0265278 A1
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Methods for generating high titer helper-free preparations of released recombinant AAV vectors183US 6,566,118 B1Targeted Genetics Corporation · 2003
- Indole analogs of mevalonolactone and derivatives thereof174US 5,354,772 ASandoz Pharm. Corp. · 1994
- Phosphinylalkanoyl substituted prolines156US 4,337,201 AE. R. Squibb & Sons, Inc. · 1982
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001